60
م ي ح ر ل ا ن م ح ر ل له ا م الس ب م ي ح ر ل ا ن م ح ر ل له ا م الس ب م ي ح ر ل ا ن م ح ر ل له ا م الس ب م ي ح ر ل ا ن م ح ر ل له ا ل م ا س ب م ي ح ر ل ا ن م ح ر ل له ا م الس ب

7 Functional Neurosurgery

Embed Size (px)

Citation preview

Page 1: 7 Functional Neurosurgery

الرحمن الله بسمالرحيم

الرحيم الرحمن الله بسمالرحمن الله بسم

الرحيم

الرحمن الله بسمالرحيم

الرحيم الرحمن الله بسم

Page 2: 7 Functional Neurosurgery

Dr. Yahya Al-MuazenConsultant Neurosurgery & Radiosurgery

&Functional Neurosurgery

Page 3: 7 Functional Neurosurgery

CT scan cut through the level of the anterior horns of the lateral ventricles.

Anterior horn of lateral ventricle

Septum pellucidum

Calcified pineal

Calcified choroid plexus in occipital horn of lateral

ventricle .

Page 4: 7 Functional Neurosurgery

Caudatenucleus

Corpuscallosum

Lateralventricle

Calcified choroid

plexus

Frontal lobe

Septum pellucidum

Skull

CT scan of skull through the level of the bodies of the lateral ventricles.

Page 5: 7 Functional Neurosurgery
Page 6: 7 Functional Neurosurgery
Page 7: 7 Functional Neurosurgery
Page 8: 7 Functional Neurosurgery
Page 9: 7 Functional Neurosurgery
Page 10: 7 Functional Neurosurgery

The segmental Cutaneous innervation of the body

Page 11: 7 Functional Neurosurgery

Deformities of the hand.(a )Radial palsy-wrist drop.(b )Ulnar nerve palsy Main

en griffe' or claw hand.(c )Median nerve

palsy – 'Monkey's hand'. )d( Volkmann's contracture - another claw hand deformity. The pink areas represent the usual distribution of anaesthesia.

Page 12: 7 Functional Neurosurgery

Functional Neurosurgery

• Parkinsonism -Anatomy

- Clinical Featur- Diagnosis

-Treatment

Page 13: 7 Functional Neurosurgery

VPL-Pallidotomy-Rationale-

Dopamine )-( Putamen )+( )+( VPL-Pallidum )+( SubthalamicNucleus

)-(

Medial Pallidum - vop/Voa - Area 6 a

Page 14: 7 Functional Neurosurgery

Indication Target

Tremor Vim,)Rigor( Suvthalamus

)dentato-thalamic fibres

Rigor Vop / Vim,)Tremor( Subthalamus

)pallido-thalamic fibres(

Thalamotomy-Present state-

Page 15: 7 Functional Neurosurgery

Indication Target

Tremor Vim,Uni - and bilateral

Stim – Parameter: 100-200 Hz, 0,5-1msec2-5 V

Side –Effects: Tingling-sensations contralateral)occasional, usually mild(

Elektrostimulation

Page 16: 7 Functional Neurosurgery
Page 17: 7 Functional Neurosurgery

Dopamine )-( Putamen )+( )+( VPL-Pallidum )+( SubthalamicNucleus

)-(

Medial Pallidum - vop/Voa - Area 6 a

VPL-Pallidotomy-Rationale-

Page 18: 7 Functional Neurosurgery
Page 19: 7 Functional Neurosurgery

VPL-Pallidotomy

Indication Target

- Akinesia, Bradykinesia VPL Pallidum- Dopamine induced dyskinesias- Rigor - Tremor

Page 20: 7 Functional Neurosurgery
Page 21: 7 Functional Neurosurgery
Page 22: 7 Functional Neurosurgery
Page 23: 7 Functional Neurosurgery

Thalamotomy in Parkinson’s Disease-Results-

Vim, Subthalamus

Tremor Complete relief initially 75%

long term 66%

Partial relief initially 18%long term 13%

Rigor Significant relief initially 80%

long term 71%

Page 24: 7 Functional Neurosurgery

Thalamotomy in Parkinson’s Disease-Results-

Vop, Subthalamus

Tremor Complete relief initially 44%

long term 35%

Partial relief initially 30%long term 25%

Unchanged 26%

Rigor Significant relief initially 82%

long term 65%

Page 25: 7 Functional Neurosurgery

Patients n=215Follow-up 6m – 8y

ResultsImprovement 93%Akinesia +++Dopamine induced dyskinesias +++Rigor ++Tremor +

ComplicationsHomonymous scotoma 7%In central lower visual field )early series

VPL-Pallidotomy-Laitinen, L., 1993-

Page 26: 7 Functional Neurosurgery
Page 27: 7 Functional Neurosurgery
Page 28: 7 Functional Neurosurgery

RelationsmaBeModellhimRontgenhim(rP)rP/M

(1) Basisline )a( AC PC

)b( Formen Monroi-PC

(2) Thalamushohe in ½ Basislinie

)a( AC – PC

)b( Foramen Monroi – PC

3) Hemispharenbreite

re/li

)a( 25,0

)b( 23,5

)a( 15,2

)b( )b( 14,0

63,5

28,0

76.5 – 1.5 =75

1.12

1.2

Page 29: 7 Functional Neurosurgery

AbstandsmaBe des Zielpunktes

(ZP)

Modellhim

(M)

rP berechnet

Mit rP/M

rP berechnet

Mit RV

Koordinaten

RoRo.Op.

(a)

Von Mitte AC PC ZP

Von FM auf Basislinie ZP

Von PC auf Basislinie ZP

(b)

Oberhalb (+)

Unterhalb (- )

Basislinie

(c)

Mitte III Ventrikel ZP re/li

Sagittal

Vertikal

Frontal re/li

7.0 Pe

14.5 M.D,II.V

Page 30: 7 Functional Neurosurgery

Future Prospects

- Grafting of stem – cells - Microinfusion of growth – factors- VPL – Pallidotomy

Surgical Treatmentin Parkinson’s Disease

Page 31: 7 Functional Neurosurgery

Vim, Subthalamus

- Motor neglect 7%

- Speech impairment 0% )unilateral(

- Bilateral 15%

Thalamotomy in Parkinson’s Disease -Side effects-

Page 32: 7 Functional Neurosurgery

Target:- Striatum

Grafts:- Adrenal tissue- Embyonal midbrain - tissue

Tissue - Transplantation

Page 33: 7 Functional Neurosurgery
Page 34: 7 Functional Neurosurgery

Radiosurgery

Brain tumor AVM Epilepsy Parkinsonism

Indication:

Page 35: 7 Functional Neurosurgery
Page 36: 7 Functional Neurosurgery

Linac Isocenter Check: + 0.32 mm+ isocenter and laser+ positioning to laser+ densitometric measurement

Displacement of Dose Center: + 0.62.mm+ stereotactic localization+ positioning device

Displacement of 80% Isodose: + 0.34 mm

+ dosimetry

__________________________________________________________Overall Accuracy: +0.78 mm

Accuracy in Linac Radiosurgery

Page 37: 7 Functional Neurosurgery
Page 38: 7 Functional Neurosurgery

30Gy 11Gy 8GyAcoustic Neuroma

Dose Gradient Shaping

Page 39: 7 Functional Neurosurgery

__________________________________

Optic pathways 8 Gy 3rd, 4th and 6th cranial nerve. 20 Gy 5th nerve. 15 Gy__________________________________

Tolerable Single Dose

Organs at Risk

Page 40: 7 Functional Neurosurgery

RS for Benign Skull - Base Tumors-Earl Series

Indications Dose__________________________________

__________________________________

__________________________________

Acoustic Neuromas 14 - 20 Gy)Stockholm, Heidelberg, Cologne(

Meningiomas)Heidelberg, Cologne(

Pituitary Adenomas 20 - 60 Gy)Stockholm, Boston(

Page 41: 7 Functional Neurosurgery

Acoustic Neuromas 10 - 13 Gy)mean 11 Gy(

Meningiomas 9 - 14 Gy)mean 12 Gy(

Pituitary Adenomas 10 - 14 Gy)mean 12 Gy(

RS for Skull - Base Tumors-Ongoing Series

Indications Dose__________________________________

__________________________________

__________________________________

Page 42: 7 Functional Neurosurgery

RS for Benign Skull - Base Tumors-Strategies

Early series__________________________________

__________________________________

__________________________________

1st priority: Dose homogeneity )few isocenters(

2nd priority: Dose conformation

Peripheral Dose: Higher

Page 43: 7 Functional Neurosurgery

_________________________________1st priority: Optimal Dose Conformation

( more isocenters)

_________________________________2nd priority: Dose homogeneity

__________________________________Peripheral Dose: Lower.

( limited by burden to organs at risk)

RS for Benign Skull - Base Tumors - Strategies

Ongoing Series:

Page 44: 7 Functional Neurosurgery
Page 45: 7 Functional Neurosurgery
Page 46: 7 Functional Neurosurgery

Treatment Planning in AVM’s

20Gy

Page 47: 7 Functional Neurosurgery

AVMa. – p. view

Stereotactic Angiography

Page 48: 7 Functional Neurosurgery

Meningioma

12 Gy10 Gy

Dose Gradient Shaping

Page 49: 7 Functional Neurosurgery

Linac – RS in a Pituitary Adenoma

18 Gy12 Gy 8 Gy

Page 50: 7 Functional Neurosurgery
Page 51: 7 Functional Neurosurgery
Page 52: 7 Functional Neurosurgery
Page 53: 7 Functional Neurosurgery
Page 54: 7 Functional Neurosurgery
Page 55: 7 Functional Neurosurgery
Page 56: 7 Functional Neurosurgery
Page 57: 7 Functional Neurosurgery
Page 58: 7 Functional Neurosurgery
Page 59: 7 Functional Neurosurgery
Page 60: 7 Functional Neurosurgery